Supplements for Surgical Site Infections

What the Research Shows

Current research into supplements for preventing or treating surgical site infections is limited, and there is no broad clinical consensus on their effectiveness. Most evidence is derived from small-scale studies or animal models, which may not translate to human surgical outcomes. Astragalus is one of the few supplements with moderate evidence suggesting it may support immune function and reduce infection rates. However, for the vast majority of other supplements, evidence remains weak or insufficient. Many substances frequently discussed in wellness circles lack rigorous, large-scale human trials to prove they can reliably prevent post-operative complications. Due to the lack of high-quality, standardized data, it is difficult to determine if these supplements provide a consistent benefit. The current body of research is often conflicting, and many claims are not supported by strong clinical evidence.

AI-generated overview based on research evidence. Not medical advice.

This page is generated from AI-analyzed evidence summaries. Evidence strength ratings are based on the quality and quantity of available research, not guaranteed effectiveness. Always consult a healthcare provider before using supplements for any health condition.

See our Editorial Policy for methodology and Medical Disclaimer.